Unihealth Consultancy Ltd.

133.55 -3.35 ▼-2.5%

29 November 2023, 03:40:16 PM
Volume: 58,000

Company Profile

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.unihealthonline.com
Market Cap 210.83 Cr.
Enterprise Value(EV) 216.96 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.99 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 27.45 Trailing Twelve Months Ending 2023-03
Industry PE 60.78 Trailing Twelve Months Ending 2023-03
Book Value / Share 10.00 Trailing Twelve Months Ending 2023-03
Price to Book Value 13.69 Calculated using Price: 136.90
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.54 Cr. 15,399,952 Shares
FaceValue 10
About Unihealth Consultancy Ltd.
The company is a healthcare service provider based out of Mumbai, India, and has an operational presence in multiple countries across the African continent.

Unihealth Consultancy Ltd. Delivery

Delivered Qty
Traded Qty

Unihealth Consultancy Ltd. Performance

1 Day
-2.45%
1 Week
-6.18%
1 Month
+0.68%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Unihealth Consultancy Ltd. Fundamental Ratios

4 years 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -16.31 60.42 29.75 36.19
Return on Capital Employed (%) 1.80 14.12 20.33 22.41
Return on Assets (%) -1.59 8.48 6.16 10.70

Unihealth Consultancy Ltd. Balance Sheet

Particulars 5 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 11 15 28 81
Non Curr. Liab. 35 37 37 37 29
Curr. Liab. 18 10 13 14 16
Minority Int. 0 0 0 0 0
Equity & Liab. 58 58 65 78 124
Non Curr. Assets 38 36 41 45 44
Curr. Assets 20 22 24 33 80
Misc. Exp. not W/O
Total Assets 58 58 65 78 124

Unihealth Consultancy Ltd. Profit and Loss

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 22 26 37 44
Other Income 1 2 1 2
Total Income 23 29 38 46
Total Expenditure -20 -20 -25 -30
PBIDT 3 9 13 16
Interest -2 -1 -5 -4
Depreciation -2 -2 -2 -3
Taxation 0 -1 -1 -2
Exceptional Items
PAT -1 5 4 8
Minority Interest 0 0 0 0
Share Associate 0 0 0
Other Related Items
Consolidated Net Profit -1 5 4 8
Adjusted EPS -1 5 4 7

Unihealth Consultancy Ltd. Cash Flow

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 4 9 1
Cash Fr. Inv. -2 0 -2 -5
Cash Fr. Finan. 1 -3 -5 3
Net Change 0 0 2 0
Cash & Cash Eqvt 1 2 2 2

Unihealth Consultancy Ltd. Shareholding Pattern

1 Qtrs 2023-09 (%)
Promoter 68.80
Public 31.20
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Unihealth Consultancy Ltd. Announcements

No Corporate Announcement found.

Unihealth Consultancy Ltd. Technical Scans

Tue, 28 Nov 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below

Unihealth Consultancy Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 285,856.77 1,202.20 +0.9%
Divi's Laboratories Ltd. 99,768.40 3,723.50 -0.9%
Cipla Ltd. 96,240.20 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. 94,596.57 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. 77,163.47 5,437.10 +1.3%
Mankind Pharma Ltd. 75,957.58 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. 70,389.88 2,089.90 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.44 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 74.91 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 27.87 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.58 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 110.63 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 59.26 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.77 2,089.90 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.78 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 7.87 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 3.88 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.71 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.87 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 9.01 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,089.90 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,089.90 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,089.90 +0.5%

Unihealth Consultancy Ltd. FAQ's

What is Unihealth Consult share price?

Can I buy Unihealth Consult shares now?

What is the Market Cap of Unihealth Consult?

What are the key metrics to analyse Unihealth Consult?

What is the 52 Week High and Low of Unihealth Consult?

What is the trend of Unihealth Consult share price?